MTCO1P10

Across TCGA pan-cancer cohorts, MTCO1P10 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MTCO1P10 data layer.

The strongest signal is observed in thymoma (THYM), where higher MTCO1P10 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO1P10 expression acts as an unfavorable survival marker, although some lineages such as COAD and ACC show a favorable association.

THYM, COAD, and LUAD are the cancer types where MTCO1P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	III,IV	0.229	1.000	<.001	72	view →
COAD	DFS	Tertile	All	0.869	0.661	.024	36	view →
LUAD	DFS	Tertile	IV	0.463	0.745	.025	21	view →
UCEC	OS	Quartile	All	0.596	0.699	.029	18	view →
SKCM	OS	Tertile	IV	0.284	0.745	.003	18	view →
ACC	OS	Median	II,III,IV	0.968	0.767	.003	16	view →
THCA	DFS	Tertile	III,IV	0.961	0.642	.028	12	view →
TGCT	DFS	Tertile	All	0.900	0.716	.021	10	view →
KICH	DFS	Tertile	II,III,IV	1.000	0.623	.031	9	view →
READ	DFS	Tertile	III,IV	0.881	0.325	.039	9	view →
LGG	DFS	Tertile	All	0.652	0.758	.024	9	view →
ESCA	DFS	Tertile	II,III,IV	0.421	1.000	.027	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MTCO1P10–THYM (OS)

Open the THYM breakdown →